EAGLE Trial CADDIE Artificial Intelligence Endoscopy

NCT05730192 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 985

Last updated 2024-07-03

No results posted yet for this study

Summary

The EAGLE study is a prospective randomized controlled multicenter parallel design trial, for the assessment of clinical performance of the CADDIE device and to confirm that the device performs as expected.

Conditions

Interventions

DEVICE

CADDIE

A colonoscopy is an examination of the bowels using a colonoscope, or a thin, flexible tube with a light and camera. It can help identify issues like colorectal cancer, polyps, and ulcers.

Sponsors & Collaborators

  • Meditrial Europe Ltd.

    collaborator INDUSTRY
  • Odin Medical

    lead INDUSTRY

Principal Investigators

  • Alessandro Repici, Prof. · Humanitas Research Hospital IRCCS, Rozzano-Milan

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-10
Primary Completion
2023-11-20
Completion
2023-11-29

Countries

  • Georgia
  • Germany
  • Italy
  • Poland
  • Spain

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05730192 on ClinicalTrials.gov